Atherosclerosis: testing the water.

E. Di Cera

DOI: https://doi.org/10.1161/01.atv.0000090960.74185.db

Abstract:Acritical regulatory pathway of the blood coagulation cascade is provided by antithrombin, a serine protease inhibitor (serpin) that specifically shuts down the activity of factor Xa and thrombin.1 Much of what we know about the mechanisms of antithrombin function has come from studies using the cofactor heparin, that allosterically activates antithrombin for optimal presentation to the target protease.1,2 In the case of factor Xa, this activation is sufficient for neutralization of enzyme function.2 The heparin-assisted activation of antithrombin is of clinical relevance as heparinoids retain center stage in anticoagulant therapy.3 However, the extracellular environment in which antithrombin functions in vivo is populated by a variety of glycosaminoglycans (GAGs) like heparin sulfate, dermatan sulfate and chondroitin sulfate (CS). GAGs have anticoagulant activity, but they often lack the heparin pentasaccharide unit required for antithrombin activation, which has raised important questions about their precise mechanism of action.